| Neysa M Koury, PA C | |
|
1355 N 205th St, Shoreline, WA 98133-3215 | |
| (206) 542-5656 | |
| Not Available |
| Full Name | Neysa M Koury |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 14 Years |
| Location | 1355 N 205th St, Shoreline, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093810152 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Association Of University Physicians | 0446162697 | 3009 |
News Archive
The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.
Surfix B.V., together with its shareholders Qurin Diagnostics B.V. and LioniX International B.V., already successfully developing bio-photonic nanochips for cancer detection and other applications, today announces an accelerated development plan to allow mass-scale COVID-19 diagnosis and immunity detection with the financial support and in close collaboration with PhotonDelta.
Extended use of a common antibiotic may prolong the time between hospitalizations for patients suffering from chronic obstructive pulmonary disease, according to a post-hoc analysis of a multicenter study which compared the hospitalization rates of patients treated with a 12-month course of azithromycin to the rates of those treated with placebo.
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has established partnerships with two prominent market access consulting agencies, DecideumCogentia and MedPass International, to support market access of its NuQ® cancer tests across Europe.
For the first time, physicians can examine the systemic burden of inflammatory arthritis simultaneously across all joints and organ systems, using the high-sensitivity, high-resolution uEXPLORER total-body positron emission tomography/computed tomography (TB-PET/CT) scanner.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neysa M Koury, PA C Po Box 50095, Seattle, WA 98145-5095 Ph: () - | Neysa M Koury, PA C 1355 N 205th St, Shoreline, WA 98133-3215 Ph: (206) 542-5656 |
News Archive
The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.
Surfix B.V., together with its shareholders Qurin Diagnostics B.V. and LioniX International B.V., already successfully developing bio-photonic nanochips for cancer detection and other applications, today announces an accelerated development plan to allow mass-scale COVID-19 diagnosis and immunity detection with the financial support and in close collaboration with PhotonDelta.
Extended use of a common antibiotic may prolong the time between hospitalizations for patients suffering from chronic obstructive pulmonary disease, according to a post-hoc analysis of a multicenter study which compared the hospitalization rates of patients treated with a 12-month course of azithromycin to the rates of those treated with placebo.
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has established partnerships with two prominent market access consulting agencies, DecideumCogentia and MedPass International, to support market access of its NuQ® cancer tests across Europe.
For the first time, physicians can examine the systemic burden of inflammatory arthritis simultaneously across all joints and organ systems, using the high-sensitivity, high-resolution uEXPLORER total-body positron emission tomography/computed tomography (TB-PET/CT) scanner.
› Verified 5 days ago
Julie Williams, Physician Assistant Medicare: Medicare Enrolled Practice Location: 15214 Aurora Ave N, Shoreline, WA 98133 Phone: 206-518-9021 | |
Jill Rose Kandora, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 20120 Ballinger Way Ne Ste A-01, Shoreline, WA 98155 Phone: 206-365-9000 Fax: 206-365-9001 | |
Jennie Yen Vu, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 16549 Aurora Ave N, Shoreline, WA 98133 Phone: 206-533-2600 | |
Dr. Susanne Jennifer Holt, ND, MA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 20068 10th Ave Nw, Shoreline, WA 98177 Phone: 206-550-7016 | |
Ms. Betty Yu, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 19930 Ballinger Way Ne, Shoreline, WA 98155 Phone: 425-778-2220 Fax: 425-778-7701 | |
Ms. Barbara Beeson, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 14731 Aurora Ave N, Shoreline, WA 98133 Phone: 206-365-0220 Fax: 206-365-6436 |